Sean Esmende, MD
Orthopaedic Surgery · Glastonbury, CTNPI 1841428000
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $26,890 of the $42,675 with a category attached, or 63.0%. 7 manufacturers reported payments, led by Medtronic at 50.1% of the total. Reporting peaked in 2019 at $12,397 and has fallen 99.7% since, to $40 in 2025.
Across 125 payments — averaging $341.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$21K
- Globus Medical$21K
- Stryker$168
- Si-bone, Inc.$72
- Boston Scientific$59
- Amgen$41
- plus $37 from 1 others
Across 86 payments — averaging $3720.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Globus Medical$320K
What the payments were for
- Consulting fees$26,89063%
- Travel & lodging$10,77925%
- Food & beverage$5,00612%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 40 | $21,384 |
| Globus Medical(2 entities) | 78 | $20,914 |
| Stryker | 1 | $168 |
| Si-bone, Inc. | 1 | $72 |
| Boston Scientific | 1 | $59 |
| Amgen | 3 | $41 |
| Johnson & Johnson | 1 | $37 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XLIF$15,214
- CD HORIZON$13,704
- MazorX - Renaissance$5,943
- ExcelsiusGPS Robotic Navigation System$2,174
- Pulse$1,626
- ALIF$483
- DIVERGENCE-L$458
- Modulus$419
- RISE-L$362
- Simplify Cervical Artificial Disc$312
- RELINE$286
- PROPEL$267
- ES2$168
- Hedron$150
- Mazor X Stealth Edition$125
How this compares
$42,675 in reported general payments places this provider in the 85th percentile of 273 orthopaedic surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methocarbamol | 198 | $2,193 |
| Gabapentin | 111 | $1,077 |
| Cyclobenzaprine Hcl | 116 | $810 |
| Diclofenac Sodium | 47 | $628 |
| Oxycodone Hcl | 81 | $556 |
| Pregabalin | 13 | $360 |
| Meloxicam | 137 | $290 |
| Methylprednisolone | 29 | $225 |
| Tramadol Hcl | 59 | $214 |
| Baclofen | 28 | $188 |
| Tizanidine Hcl | 14 | $112 |
| Naproxen | 13 | $96 |
| Hydromorphone Hcl | 19 | $86 |
| Amoxicillin | 19 | $23 |
| Diazepam | 14 | $22 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Glastonbury
- Peter WhangNew Haven$1.8M
- Paul SethiGreenwich$1.5M
- James YueShelton$1.3M
- Robert DeveneyDanbury$907K
- James PaceFarmington$721K
- Isaac MossFarmington$676K
- David FrumbergNew Haven$288K
- John KeggiMiddlebury$264K
- Lauren GeaneyFarmington$263K
- Robert StantonFairfield$199K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.